Evidence map›Paper›PMID 33746713›Full record

ArticleFrontiers in cellular neuroscience2021

Synaptic Function and Dysfunction in Lysosomal Storage Diseases.

Rima Rebiai, Maria I Givogri, Swetha Gowrishankar, Stephania M Cologna, Simon T Alford, Ernesto R Bongarzone

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rima RebiaiDepartment of Anatomy and Cell Biology, College of Medicine, The University of Illinois at Chicago, Chicago, IL, United States.
Maria I GivogriDepartment of Anatomy and Cell Biology, College of Medicine, The University of Illinois at Chicago, Chicago, IL, United States.
Swetha GowrishankarDepartment of Anatomy and Cell Biology, College of Medicine, The University of Illinois at Chicago, Chicago, IL, United States.
Stephania M ColognaDepartment of Chemistry, College of Liberal Arts and Sciences, The University of Illinois at Chicago, Chicago, IL, United States.
Simon T AlfordDepartment of Anatomy and Cell Biology, College of Medicine, The University of Illinois at Chicago, Chicago, IL, United States.
Ernesto R BongarzoneDepartment of Anatomy and Cell Biology, College of Medicine, The University of Illinois at Chicago, Chicago, IL, United States.
University of Illinois Chicago · US

Funding

Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
Regulation of exocytosis by direct Gbg blockade of fusionR01NS111749 · NINDS · VANDERBILT UNIVERSITY · PI ALFORD, SIMON T, HAMM, HEIDI E · 2019 to 2023
$2.0M
Development of autophagy modulators for evaluation as a therapeutic strategy for Niemann-Pick Type CR01NS114413 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COLOGNA, STEPHANIE M · 2020 to 2024
$2.0M
NINDS NIH HHS R01 NS065808NINDS NIH HHS R01 NS111749NINDS NIH HHS R01 NS114413
6 · The paper itself

Abstract

Lysosomal storage diseases (LSDs) with neurological involvement are inherited genetic diseases of the metabolism characterized by lysosomal dysfunction and the accumulation of undegraded substrates altering glial and neuronal function. Often, patients with neurological manifestations present with damage to the gray and white matter and irreversible neuronal decline. The use of animal models of LSDs has greatly facilitated studying and identifying potential mechanisms of neuronal dysfunction, including alterations in availability and function of synaptic proteins, modifications of membrane structure, deficits in docking, exocytosis, recycling of synaptic vesicles, and inflammation-mediated remodeling of synapses. Although some extrapolations from findings in adult-onset conditions such as Alzheimer's disease or Parkinson's disease have been reported, the pathogenetic mechanisms underpinning cognitive deficits in LSDs are still largely unclear. Without being fully inclusive, the goal of this mini-review is to present a discussion on possible mechanisms leading to synaptic dysfunction in LSDs.

Indexed as

cholesterolGABAglutamate receptorsLTDLTPlysosomessphingolipidssynapses

Identifiers

PMID33746713
PMCPMC7978225
OpenAlexW3135594502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.